GLP-1 Analogues Market Set to Surpass USD 211.8 Billion by 2035 as Diabetes and Obesity Cases Rise Globally
The global GLP-1 analogues market is undergoing a transformative phase, fueled by the growing burden of type 2 diabetes, obesity, and cardiometabolic disorders worldwide. According to recent market estimates, the industry was valued at US$ 51.6 billion in 2024 and is expected to reach US$ 211.8 billion by 2035, growing at a robust CAGR of 13.7% from 2025 to 2035. GLP-1...
0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior
BuzzingAbout https://www.buzzingabout.com